Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Titel:
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Auteur:
Palanca-Wessels, Maria Corinna A Czuczman, Myron Salles, Gilles Assouline, Sarit Sehn, Laurie H Flinn, Ian Patel, Manish R Sangha, Randeep Hagenbeek, Anton Advani, Ranjana Tilly, Herve Casasnovas, Olivier Press, Oliver W Yalamanchili, Sreeni Kahn, Robert Dere, Randall C Lu, Dan Jones, Surai Jones, Cheryl Chu, Yu-Waye Morschhauser, Franck